RhemaStem offers consulting services in the area of solid cancer stem cells (Colon, Lungs, Brain, Breast, Prostrate, Ovarian, Circulating tumor cells and other cancers) from isolation to production and wishes to discuss the opportunity to collaborate with commercial partners in the field of cancer stem cell drug discovery, sponsored collaborative research programmes or fee-for-service activities will be considered.

What makes us different

  • Cumulative years of experience in solid cancer stem cell technology.
  • A more efficient system.
  • Increase productivity.
  • A consistent baseline.
  • Exclusive approaches and creative solutions.